Clinical observation of simultaneous continuous infusion of fluorouracil and disodium folinate combined with oxaliplatin for metastatic colorectal cancer
Year: 2012
Type: article
Abstract: Objective To observe the efficacy and adverse effects of simultaneous continuous infusion of fluorouracil(5-FU) and disodium folinate(Na-FA) combined with oxaliplatin comparing to mFOLFOX6 regimen in metastatic colorectal cancer,and to evaluate the feasibility of calcium folinate(Ca-FA) substituted by Na-FA.Methods A total of 54 patients with measurable metastatic colorectal cancer for whom had no previous FOLFOX treatment,were received infusion of disodium folinate and fluorouracil simultaneously regimen(group Na-FA,n=30) and mFOLFOX6 regimen(group Ca-FA,n=24).The regimens were taken as follow,group Na-FA: oxaliplatin 85 mg/m2 iv d1,5-FU 0.4 g/m2 bolus d1,and 5-FU 2.4g/m2 mixed with Na-FA 0.4g/m2 infusion 46 hours.Group Ca-FA: oxaliplatin 85mg/m2 iv d1,Ca-FA 0.4g/m2 iv d1,5-FU 0.4g/m2 bolus d1,and 5-FU 2.4g/m2 infusion 46 hours.Fourteen days was a cycle for both 2 groups.The short term effects and safety of the two groups were evaluated according to the RECIST entity tumors evaluation criteria and anticancer drugs common toxicity grading criteria after 4 cycles.Results There were 3 CR,13 PR and 10 SD in group Na-FA,and the response rate and disease control rate were 53.3% and 86.7%;there were 1 CR,11 PR and 9 SD in group Ca-FA,and the response rate and disease control rate were 50.0% and 87.5%.There was no significant difference in the two groups.The common side effects were grade 1-2 gastric reactions,grade 1-2 myelosuppression and grade 1-2 hair loss.The incidence rates of side effects were no statistical difference between the two groups.Conclusion Continuous infusion of disodium folinate and 5-FU simultaneously for patients with colorectal cancer is safe,effective and convenient.As the result,calcium folinate can be substituted by disodium folinate in mFOLFOX regimen.
Source: Chinese Clinical Oncology
Author: Yin Xian
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2380854108
